key: cord-0791369-k5u188oa
authors: Stanojevic, Slavoljub; Ponjavic, Mirza; Stanojevic, Slobodan; Stevanovic, Aleksandar; Radojicic, Sonja
title: Simulation and prediction of spread of COVID-19 in The Republic of Serbia by SEIRDS model of disease transmission
date: 2021-03-11
journal: Microb Risk Anal
DOI: 10.1016/j.mran.2021.100161
sha: aab18ad35de75724230922411a7ff52e43517cd8
doc_id: 791369
cord_uid: k5u188oa

As a response to the pandemic caused by SARS-Cov-2 virus, on 15 March, 2020, the Republic of Serbia introduced comprehensive anti-epidemic measures to curb COVID-19. After a slowdown in the epidemic, on 6 May, 2020, the regulatory authorities decided to relax the implemented measures. However, the epidemiological situation soon worsened again. As of 7 February, 2021, a total of 406,352 cases of SARSCov-2 infection have been reported in Serbia, 4,112 deaths caused by COVID-19. In order to better understand the epidemic dynamics and predict possible outcomes, we have developed an adaptive mathematical model SEAIHRDS (S-susceptible, E-exposed, A-asymptomatic, I-infected, H-hospitalized, R-recovered, D-dead due to COVID-19 infection, S-susceptible). The model can be used to simulate various scenarios of the implemented intervention measures and calculate possible epidemic outcomes, including the necessary hospital capacities. Considering promising results regarding the development of a vaccine against COVID-19, the model is extended to simulate vaccination among different population strata. The findings from various simulation scenarios have shown that, with implementation of strict measures of contact reduction, it is possible to control COVID-19 and reduce number of deaths. The findings also show that limiting effective contacts within the most susceptible population strata merits a special attention. However, the findings also show that the disease has a potential to remain in the population for a long time, likely with a seasonal pattern. If a vaccine, with efficacy equal or higher than 65%, becomes available it could help to significantly slow down or completely stop circulation of the virus in human population. The effects of vaccination depend primarily on: 1. Efficacy of available vaccine(s), 2. Prioritization of the population categories for vaccination, and 3. Overall vaccination coverage of the population, assuming that the vaccine(s) develop solid immunity in vaccinated individuals. With expected basic reproduction number of R(o)=2.46 and vaccine efficacy of 68%, an 87% coverage would be sufficient to stop the virus circulation.

 An augmented multi-compartment SEAIHRDS model was used to analyse different scenarios of COVID-19 pandemic and required hospital capacities.  The model demonstrates that COVID-19 has a potential to spread rapidly and linger in the population and probably will have a seasonal pattern.  Depending on the efficacy of future vaccines, the disease can be stopped and curbed almost solely by implementing the vaccination.  The necessary conditions for successful control of COVID-19 by vaccination in the future are the efficacy of potential vaccines and the ability of a health system to implement vaccination to a satisfactory extent. Keywords: COVID-19, SEAIHRDS mathematical model, prediction, vaccination

On 11 March, 2020, the World Health Organization characterised the disease caused by the novel SARS-Cov-2 virus as a pandemic [1] . The Initial epidemic outbreak in China spread outside the For these reasons, mathematical modelling has a crucial role in understanding the epidemic and predicting possible outcomes. Modelling is a particularly useful tool for devising strategies for combating the epidemic, capacity planning, and selection of efficient measures, especially in the absence of specific pharmaceutical treatments [3, 4, 5] . Mathematical modelling based on differential equations dates back to the first half of 20 th century. In 1927, Kermack and McKendrick developed the basic model of disease transmission consisting of three compartments: susceptible (S), infected (I) and removed (R). The model was based on a connected system of nonlinear differential equations as a special case of the general epidemiological model [6, 7] . Subsequent models, became more complex and adapted to the needs of research [5] . 

This section presents the research methodology and the proposed model, which were used to predict the further dynamics of the epidemic in Serbia. We also presented the data that were used to model the epidemic, a simulated strategy to combat COVID-19, and a sensitivity analysis.

Classical SEIRDS model divides the population into compartments, i.e. groups, and follows the disease dynamics at all times. The population is divided into the following compartments: the portion of the population susceptible to the infection is denoted by S, those latently infected with SARSCov-2 (exposed to) are denoted by E, the infected individuals who are able to spread the disease are denoted by I, the ones recovered from the infection are denoted by R, and those who died due to disease with D.

Assuming that individuals mix homogenously, the force of infection λ (the rate at which susceptible persons are infected) is related to per capita contact rate . Also, the risk of infection is closely related to the number of infectious individuals in the population I t . It depends on the number of infectious individuals (I t ) and how frequently they make contacts with other persons. In a situation of homogenous mixing among the population, the force of infection λ can be express as follows:

The change of rates in every compartment per unit time in SEIRDS model is presented in the following series of differential equations:

Et+1= StIt -ƒE − mEt (3) It+1=ƒEt -(r+m)It -δIt (4) Rt+1=rIt -(m+ω)Rt (5) Dt+1= δIt (6) where ƒ is rate of onset of infectiousness expressed as the reciprocal of the latent infection period, r is the rate at which infectious individuals are recovered, δ is the rate at which infectious individuals die from COVID-19 infection and ω is rate of waning of immunity. The total population at any particular interval of time t is:

where parameters b and m are per capita daily birth rate and death rate unrelated to COVID-19. 

where λi(t) is force of infection in the i th population strata, ij is the rate at which susceptible persons in the i th population strata and infectious persons in j th population strata come into effective contact per unit of time, and Ij(t) is the number of infectious persons in j th population strata. Also, in this model the number of recovered and dead is conditioned with different ages and genders.

Now our model will be expressed as follows:

where α is the proportion of asymptomatic cases, η accounts for the relative infectiousness of asymptomatic carriers (in comparison to symptomatic carriers), r is the rate at which infectious individuals whit symptoms are recovered, γ is the rate at which asymptomatic infectious individuals are recovered, is rate at which infectious individuals are hospitalized, ε is the rate at which hospitalized patients are recovered, δ is the rate at which infected individuals die from COVID-19 infection and ω is rate of waning of immunity (Supplementary material).

Considering the undergoing worldwide efforts to develop a vaccine against COVID-19 and promising results, we extended the model to simulate and analysed the effects of a hypothetical vaccination on the epidemic dynamics, and to estimate the extent of coverage of vaccination which can interrupt the chain of infection. The control of COVID-19 by vaccination means targeting the entire susceptible population with mass vaccination until critical herd immunity achieved. In such situation there is a "race" between the exponential growth of epidemic and mass vaccination. The level of herd immunity threshold (HIT) can be calculated by the following formula: HIT = − /Ro = (Ro−1)/Ro (16) and the critical vaccination coverage required to achieve herd immunity can be obtained by multiplying herd immunity threshold with reciprocal value of vaccine efficacy, v e :

Most people infected with SARS-CoV-2 develop an immune response followed by the development of specific antibodies between 10 and 21 days after getting infected [12] . Specific IgM and

IgG antibodies against SARS-CoV-2 develop 6 to 15 days after the onset of the disease [13] [14] [15] [16] [17] .

According to some studies, the presence of antibodies has been confirmed in less than 40% of the patients within 1 week after the onset of the disease, whereas percentage reaches 100% of subjects 15 days after the onset of disease [18] . Although duration of the immune response against CVOVID 19 is still unknown, comparing with other coronaviruses, where immunity wane within 12 to 52 weeks after the first symptoms appear [19, 20] , while in the case of SARS-CoV-1 infection the presence of IgG antibodies was confirmed in 90% and 50% of infected patients, respectively, over two and three years, respectively [29] , we assumed that durable immunity against COVID-19 is possible [20, 21] . Immunity to HCoVOC43 and

HCoV-HKU1 appears to wane appreciably within 1 year [21, 22] , whereas SARS-CoV-1 infection can induce longer-lasting immunity [23] . S. F. Lumley et. in a study conducted on 1,246 persons recovered from COVID-19 found no symptomatic re-infections over 6 months [24] .

Based on these findings, and fact that SARS-Cov-2 virus is also beta coronavirus, we assumed that in the event of the development of a successful vaccine, immunity against the SARS-Cov-2 virus could last for a year, as well as after recovery after a natural infection. In a study conducted to determine the dynamics of SARS-Cov-2 transmission in the post pandemic period, Kissler et al. applied a similar approach in defining the possible length of the immunity period [20] . x ve [5] . In this compartment the daily rate of waning of immunity at which immunity of vaccinated population fades out is ω, and it is reciprocal to the period of lasting of immunity. Vaccinated persons, after losing their immunity, become sensitive again and removed to the compartment S. The change of rate in this compartment per unit time is as follows:

The compartment S(t) is slightly modified as follows:

The other of compartments of SERIDS model remain unchanged.

In proposed model, is per capita effective contact rate at which specific persons come into effective contact per unit of time. An effective contact is defined as a contact sufficient to cause disease transmission [10, 24, 26] . We calculated the parameter by using the formula:

where R o is a basic reproduction number of the disease, i.e. the average number of newly infected people with COVID-19 (secondary infection cases), infected by one infectious individual in a totally susceptible population, N is total population, and T R is the average duration of infectious period [10, 25, 26] . The R values of 2.46 and 3.1 are adopted from the relevant literature. The R o values were based on the data obtained during the initial phase of the epidemic in Italy [27] . Since the implemented measures and disease transmission were simulated through various population strata, we corrected the parameter with a relevant, stratum-specific contact reduction factor ρ i . In this way, we obtained the per capita contact rate specific for each separate stratum based on following formula

The values of the ρ i factor in different population strata ranged from 0.25 to 0.75 (effective contact reduction ranged from 25% to 75%).

Parameters such as daily birth and death rates were calculated based on the data published by ) and the average period during which an infected person is shading the SARS-Cov-2 virus (T R ) were adopted from the relevant literature as ƒ -1 = 3.5 days [30, 31] and T R = 9.3 days, respectively [30] . Also the data on the percentage of hospitalized patients and those whose therapy requires intensive care, used for prediction of required hospital capacities, as shown in Table 1 , were taken from literature [30, 8] .

Parameters such as δ and r are related to the infectious fatality rate (IFR) for COVID-19 and average times taken from onset of symptoms to death (T D ) or recovery (T R ). These parameters were calculated using the following formulas:

The IFRs, shown in Table 3 .

Five different scenarios were developed for simulating the COVID-19 epidemic control based on non-pharmaceutical interventions. SC1 implies a base-case scenario where the epidemic spreads in susceptible population without any anti-epidemic measures being implemented. In the other scenarios, the extent of contacts was reduced, for each population stratum separately, according to objective possibilities and measures which were implemented during the actual epidemic in the Republic of Serbia.

Scenarios are presented in Table 4 . Additional four scenarios of control of COVID-19 were simulated based on vaccination policy. We assumed that vaccine efficacy was 50%, 68%, 80%, and 85%. The initial conditions assumed that all other anti-epidemic measures are excluded from the model and replaced with mass vaccination.

Indicators of epidemic dynamics were monitored, such as: CI, hospitalized patients, patient in intensive care units and deaths.

Considering the world experience with detection of COVID-19 cases, as well as the unreliable data on COVID-19 infections which are currently available worldwide, model calibration is very challenging, and can result in obtaining inaccurate values for the parameters [40] . This is especially due to the facts that a significant percentage of the infected individuals do not exhibit any symptoms. The other issue is small percentage of tested population [40] . [39] .

Due the fact that there is a lag in time between when people are infected and when they die, patients who die on any given day were infected much earlier, and thus the denominator of the mortality rate should be the total number of patients infected at the same time as those who died [41] . David et al.

estimated mortality rate by dividing of deaths on a given date by the total number of persons confirmed as COVID 19 cases 14 days before [29, 41] . It is based on the assumption that maximum incubation period is14 days [34] . However, if we take into account that the number of registered cases of COVID-19 infection is usually significantly lower than the actual number, assuming that the data on deaths are accurate, the real IFR value is significantly lower than the calculated value [40] . Taking these findings into account, we decided to take the IFR values specific to certain population strata recorded in Spain as the most appropriate for our case [33] . The adopted IFR values are listed in Table 3 .

In this section, we used sensitivity analysis to estimate the amount of change on outcomes when varying the input values used in the model. Sensitivity analysis is one of the methods most frequently used for the evaluation of disease spread models [51, 52] . A sensitivity analysis is carried out to characterise the impact of uncertainty of input parameters on model outputs. Sensitivity analysis consists of assessing the impact that changes in input parameters have on model outcomes. We evaluate two aspects of the model: the global behavior of the model when perturbing a group of key parameters together, and the impact of changes when perturbing the key parameters used in the model individually.

The model sensitivity analysis was conducted by changing the most sensitive model parameters:

R0, β, ƒ-, r, b, m, γ, ε, η, ω, d . The values of these parameters were increased by 5%, 10% and 25%

relative to the base scenario and changes in output indicators were observed. 

After the simulation, the model predicted that with R o = 2. 46 consequences.

With R o = 3.1, the following results were obtained: the initial doubling time of the infection was five days, true cumulative incidence 7,133,221, apparent cumulative incidence 4,993,254, and the total deaths of 23,951. Fig. 1, panels a) increasing, and therefore all of the following hold: R n >1, proportion susceptible >1/R o and the proportion of population that is recovered (immune) is below the herd immunity threshold. Fig. 2 panels a) and b) show a prediction of necessary hospital capacities. Panels c) and d) of Fig. 2 show predicted numbers of sick and dead due to COVID-19 at R o =2.46 and R o =3 and age structure of hospitalized patients and deaths. Table 5 and in Fig. 3 and Fig. 4) . Openings of pre-school and elementary school's facilities leads to a visible jump in the number of infected and hospitalized in all strata. This finding clearly shows that children, although least susceptible to developing more severe clinical pictures, are important when transmitting SARS-Cov-2 (Scenario 3 in Table 5 and Fig. 3) . Opening of the high schools and colleges also leads to a visible increase in the number of newly infected and hospitalized patients, including an increase in the number of deaths (Scenario 5 in Table 5 and Fig. 3 (Fig. 4 ).

Assuming that the disease is spreading at the basic reproduction number of R o =2. 46 

The results of the sensitivity analysis are presented in tables 6 and 7. The tables show increased values of input parameters and the percentage of the parameter increase relative to the basic scenario, as well as the values of output results obtained after the simulation of the changed scenario.

The model was validated on the most recent historical data (from January 1, 2021 to February 1, 2021). As shown in Table 8 . all measures of the prediction quality of deceased due to COVID-19 are low.

The average difference between the actual number of people who died of COVID-19 and predicted one is only 2.05% and the maximum deviation between the predicted and actual number will not exceed 4.82%

with a probability of 95%.

Based on Fig. 6 and Table 9 , we can conclude that the SEAIHRD model fits historical data quite well. Pearson's r and coefficient of determination (R 2 ) have shown strong the linear relationship between real deceased and the number of deaths predicted by SEAIHRD model.

More information on validation results are detailed in the supplementary material.

For the needs of this research, we augmented the classic deterministic model by adding the compartments of vaccinated, asymptomatic, hospitalized and latently infected subjects. By adding birth and death rates, we enabled daily fluctuations of the overall simulated population, which brought us closer to the real conditions in which the disease is transmitted. When we assumed that the recovered lose immunity over time, we obtained dynamic oscillations of epidemic waves through susceptible population.

The input values for the parameters used to simulate the COVID-19 were obtained either from literature review or were calculated on the basis of data have taken from the literature and other official sources. Whereas some of these inputs are well documented; other input values are either not so well documented or based on potential subjective opinions (i.e., expert opinion, historical data from epidemic etc.). In any case, well documented or not input values have potential to impact results and, therefore, should be carefully evaluated. The results of conducted sensitivity analysis show that the sources of uncertainty are different for each output considered and it is necessary to consider multiple output variables for a proper assessment of the model. The most influential parameter is r than R 0 and ƒ --1 .

The model was tested on Serbian COVID-19 statistic data and obtained validation results allow us to conclude that the proposed model has good prediction ability and performance. However, although we obtained satisfactory results during the validation of the model, worth noticing also that some of the model parameters were estimated based on available data that might be less precise due to the difficulty of being measured. That could be the reason why the values of some parameters e.g. recovery rate, contact rate, daily infection rate, that are estimated in hospitals may differ from those acquired by this study. For that reasons SEAIHRD model can be used for the long-term rough predictions of the epidemic.

Obtained long-term predictions reflect the general dynamic of the outbreak and are especially useful for the healthcare system workers and governmental officials. 

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Funding: This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. 

World Health Organization (WHO), Coronavirus disease (COVID-19) outbreak situation

Extended SIR prediction of the epidemics trend of COVID-19 in Italy and compared with Hunan

Early dynamics of transmission and control of COVID-19: a mathematical modelling study. The Lancet infectious diseases 2020

Modelling Infectious Diseases in Humans and Animals

A contribution to the mathematical theory of epidemics

Mathematical modelling with case studies Using Maple™ and MATLAB

Impact of non-pharmaceutical interventions (NPIs) to reduce COVID-19 mortality and healthcare demand

Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a Report of 72 314 Cases from the Chinese Center for Disease Control and Prevention

White with an introduction by Paul E.M. Fine. An Introduction to Infectious Disease Modelling

European Centre for Disease Prevention and Control

CoV-2

Clinical presentation and virological assessment of hospitalized cases of coronavirus disease 2019 in a travel-associated transmission cluster

Evaluation of Nucleocapsid and Spike Proteinbased ELISAs for detecting antibodies against SARS-CoV-2. medRxiv

Antibody responses to SARS-CoV-2 in COVID-19 patients: the perspective application of serological tests in clinical practice

Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019

SARS-CoV-2 specific antibody responses in COVID-19 patients

Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019

The dynamics of humoral immune responses following SARS-CoV-2 infection and the potential for reinfection. The Journal of general virology

Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period

The time course of the immune response to experimental coronavirus infection of man

Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection Science

Cross-reactive antibodies in convalescent SARS patients' sera against the emergingnovel human coronavirus EMC (2012) byboth immunofluorescent and neutralizingantibody tests

Antibodies to SARS-CoV-2 are associated with protection against reinfection

Blackwell Science Ltd, a Blackwell Publishing company

Assessment of the SARS-CoV-2 basic reproduction number, R0, based on the early phase of COVID-19 outbreak in Italy

World Developments Indicators

ds=d5bncppjof8f9_&met_y=sp_dyn_le00_in&idim=country:S RB:HRV:BIH&hl=en&dl=en#!ctype=l&strail=false&bcs=d&nselm=h&met_y=sp_dyn_le00_in&scale_y=lin& ind_y=false&rdim=world&idim=country:SRB&ifdim=world&hl=en_US&dl=en&ind=false

Inferred duration of infectious period of SARS-CoV-2: rapid scoping review and analysis of available evidence for asymptomatic and symptomatic COVID-19 cases

Epidemiological parameters of coronavirus disease 2019: a pooled analysis of publicly reported individual data of 1155 cases from seven countries

Estimates of the severity of coronavirus disease 2019: a model-based analysis

Infection fatality risk for SARS-CoV-2: a nationwide seroepidemiological study in the noninstitutionalized population of Spain. medRxiv

Assessment of the SARS-CoV-2 basic reproduction number, R0, based on the early phase of COVID-19 outbreak in Italy

Incubation period of COVID-19: a rapid systematic review and meta-analysis of observational research

Trajectories of Hospitalization in COVID-19 Patients: An Observational Study in France

Incubation Period and Other EpidemiologicalCharacteristics of 2019 Novel Coronavirus Infections with Right Truncation: A Statistical Analysis of Publicly Available Case Data

Epidemiological parameters of coronavirus disease 2019: a pooled analysis of publicly reported individual data of 1155 cases from seven countries

SARS-CoV-2 Transmission From People Without COVID-19 Symptoms

Simulating the spread of COVID-19 via a spatially-resolved susceptible-exposed-infected-recovered-deceased (SEIRD) model with heterogeneous diffusion

Real estimates of mortality following COVID-19 infection. The Lancet

Estimating the COVID-19 infection rate: Anatomy of an inference problem

CDC

Covid-19: identifying and isolating asymptomatic people helped eliminate virus in Italian village

Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: A living systematic review and metaanalysis

Towards an accurate and systematic characterisation of persistently asymptomatic infection with SARS-CoV-2

Centre for Evidence-Based Medicine develops, promotes and disseminates better evidence for healthcare. Estimating the infection fatality ratio in England

Did COVID-19 infections decline before UK lockdown?

Predicted COVID-19 Fatality Rates Based on Age, Sex, Comorbidities, and Health System Capacity

A novel spatial and stochastic model to evaluate the within and between farm transmission of classical swine fever virus: II Validation of the model

Monte Carlo simulation of classical swine feverepidemics and control II. Validation of the model